Asia Pacific Smart Inhalers Market

The Asia Pacific smart inhalers market is expected to reach US$ 1,539.97 Mn in 2027 from US$ 186.63 Mn in 2018. The market is estimated to grow with a CAGR of 27.2% from 2019-2027.

With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Asia Pacific. Some of the factors leading to growth in the number of asthma and COPD cases across the Asia Pacific are a rise in air pollution levels and increasing smoking habits.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into the lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. In 2016 Among the 2.2 million air pollution-related deaths in Asia pacific region, 29% were due to heart disease, 27% stroke, 22% chronic obstructive pulmonary disease, 14% lung cancer and 8% pneumonia. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. In 2017 World Health Organization (WHO) held a member states consultation on addressing the health impact of air pollution in the western pacific region, and continues to take steps to improve the situation. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period

In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

China is expected to lead the market in the Asia Pacific region because the growing prevalence of asthma and COPD Across the country. According to the recent report published in the Lancet, Approximately 9% of china’s adult population about to 100 million people are suffering with chronic obstructive pulmonary disease (COPD). Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

Rest of Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Asia Pacific Smart Inhalers Strategic Insights

Strategic insights for the Asia Pacific Smart Inhalers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Smart Inhalers Report Scope

Asia Pacific Smart Inhalers Regional Insights

The geographic scope of the Asia Pacific Smart Inhalers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

ASIA PACIFIC SMART INHALERS – MARKET SEGMENTATION

By Product

• Inhalers
• Nebulizers

By Disorder

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End User

• Home-care Settings
• Hospitals & Clinics

By Geography

• Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Company Profiles

• GlaxoSmithKline plc
• Adherium Ltd.
• Vectura Group plc
• Novartis AG
• Findair Sp. z o. o.
• Cohero Health
• Crux Product Design Ltd
• Teva Pharmaceuticals
• 3M
• Amiko Digital Health Limited